MYD88 and diffuse large B-cell lymphoma: The pathogenesis of THRLBCL involves several genetic alterations also seen in DLBCL, including overexpression of BCL2 and mutations in TNFAIP3 and MYD88 (L265P), which promote tumor cell survival.